Similar to pulmonary fibrosis, inhibiting IL11 signaling suppresses the phosphorylation of Erk, thereby reducing liver fibrosis in NASH mice [44]. The gene discussed is IL11; the disease is metabolic dysfunction-associated steatohepatitis.